Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis.
about
Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Prognostic and clinicopatholog ...... RISMA-compliant Meta-analysis.
@en
Prognostic and clinicopatholog ...... RISMA-compliant Meta-analysis.
@nl
type
label
Prognostic and clinicopatholog ...... RISMA-compliant Meta-analysis.
@en
Prognostic and clinicopatholog ...... RISMA-compliant Meta-analysis.
@nl
prefLabel
Prognostic and clinicopatholog ...... RISMA-compliant Meta-analysis.
@en
Prognostic and clinicopatholog ...... RISMA-compliant Meta-analysis.
@nl
P2860
P1433
P1476
Prognostic and clinicopatholog ...... RISMA-compliant Meta-analysis.
@en
P2093
P2860
P356
10.1097/MD.0000000000010195
P407
P577
2018-03-01T00:00:00Z